Plastic Surgery Post-Op Monitoring

Why Plastic Surgery Is Ideal for Post-Operative RTM

Remote therapeutic monitoring (RTM) is purpose-built for the extended post-operative recovery period that characterizes reconstructive plastic surgery. Unlike outpatient medical specialties where RTM monitors chronic disease states, plastic surgery RTM captures the dynamic, time-sensitive changes of surgical wound healing — making it both clinically valuable and straightforwardly documentable for billing purposes.

Post-operative plastic surgery patients face a recovery arc of weeks to months, during which wound healing complications — wound dehiscence, seroma formation, hematoma, infection, implant pocket issues, and flap perfusion compromise — can escalate rapidly if not identified early. Traditional follow-up schedules (post-op day 1–2, 1 week, 3 weeks, 6 weeks) leave significant surveillance gaps. A patient who develops subtle signs of wound edge separation on post-op day 10 — between the week-1 and week-3 visits — may present at the 3-week appointment with a fully dehisced wound requiring OR intervention that could have been managed conservatively with early identification.

RTM addresses this gap by creating a continuous monitoring channel: patients submit daily wound photos, drain output logs, pain scores, and activity restriction compliance reports through a mobile app. Your clinical team reviews submissions on a defined schedule (daily for high-risk patients, every 48–72 hours for stable patients) and intervenes when submission data indicates a concerning trend. This clinical workflow is reimbursable under CPT 98975 (initial setup), CPT 98977 (monthly device/software fee), CPT 98980 (first 20 minutes of RTM management per month), and CPT 98981 (additional 20-minute increments).

For a practice with 50–60 reconstructive patients enrolled in RTM, the monthly revenue contribution is $5,500–$8,500 depending on payer mix and the percentage of patients generating add-on 98981 codes — revenue that reflects genuine clinical value delivered outside the exam room.

Wound Healing Photo Tracking: Incision and Flap Perfusion

The cornerstone of post-operative RTM in plastic surgery is standardized wound photography. Unlike the casual smartphone photo that patients already take and text to their surgeons (an unstructured, non-reimbursable activity), RTM wound photography uses a defined protocol that generates clinical data suitable for review and documentation.

For incision healing monitoring, the standardized photo protocol requires: a ruler or calibrated reference in the frame for size measurement, consistent overhead angle (perpendicular to the wound surface, not angled), adequate lighting (natural or supplemental daylight-balanced, no flash that whitens out tissue color detail), and photo capture at defined anatomical sites based on the procedure. For abdominoplasty: the full incision from hip to hip plus the umbilicoplasty site. For breast procedures: bilateral incision sites (inframammary fold, periareolar, or mastopexy scar pattern) plus a frontal breast view. For face lift: bilateral periauricular incision sites and the temporal hair-bearing incision.

For flap perfusion monitoring in autologous reconstruction (DIEP, TRAM, latissimus dorsi flap, pedicled TRAM), photo monitoring serves an early-warning function for partial flap loss — the most feared early complication of free flap reconstruction. Key visual indicators of perfusion compromise: skin color change (pale or mottled purple, vs. expected pink or red), capillary refill > 2 seconds (patients can be taught to assess this with a fingernail press), skin turgor change (tight/shiny vs. normal), and temperature change (cool flap vs. warm surrounding tissue — infrared thermometer can detect this). Patients with DIEP or TRAM reconstruction should submit photos every 4–6 hours in the first 48 hours post-discharge (the highest-risk window for flap compromise) and daily thereafter for the first 2 weeks.

For implant pocket monitoring in breast augmentation or two-stage reconstruction (tissue expander to permanent implant), wound photos track: the inferior pole descent of the implant as the pocket matures, capsule firmness concerns (difficult to assess remotely, but patient-reported firmness scores are documentable), and incision healing quality at the inframammary fold or periareolar site.

Drain Output Monitoring and Protocol Management

Surgical drains (Jackson-Pratt, Blake, or bulb suction drains) are placed after many reconstructive plastic surgery procedures — abdominoplasty, post-mastectomy reconstruction, flap harvest sites, and extensive skin excision procedures — to prevent seroma formation by continuously removing fluid from the surgical dead space. Drain output monitoring is a clinical necessity for determining when drains can safely be removed, and it is a natural fit for RTM documentation.

The standard drain removal criterion is output below 30 mL per 24 hours for two consecutive days — a threshold that applies to most soft-tissue drains. However, drain output often follows a non-linear pattern: high in the first 48–72 hours (50–150 mL/day), gradually declining, with occasional spikes from activity or position change. Remote monitoring of drain output allows your clinical team to identify unexpected output spikes (possible seroma or hematoma formation) and to confirm the drain removal threshold has been met without requiring an office visit.

In the RTM protocol, patients record drain output twice daily (morning and evening) in the app, logging the volume from each drain separately (labeled Left, Right, or by anatomical site). The system flags any 24-hour output exceeding a defined threshold — for example, if a patient's abdominoplasty drain output spikes from 28 mL to 95 mL on post-op day 10, this triggers an immediate clinical review. The reviewing clinician calls the patient to assess for hematoma symptoms (rapid swelling, firmness, pain), determines whether an urgent visit is warranted, and documents the clinical decision in the RTM record.

The drain removal decision is documented in the RTM record as a clinical management action under 98980: the clinician reviews the two-day output log, confirms the threshold has been met, documents the drain removal instructions provided to the patient or visiting nurse (for patients with home health), and records the clinical reasoning. This documentation is both good patient care and precisely the type of RTM management activity CMS recognizes as billable — a clinical decision made based on remotely monitored data, communicated to the patient.

Pain Management and Activity Restriction Compliance

Post-operative pain management and activity restriction compliance are RTM monitoring categories that extend beyond wound care and capture the behavioral and functional dimensions of post-surgical recovery. These metrics are directly relevant to outcomes — patients who are non-compliant with activity restrictions have higher rates of wound complications, implant displacement, seroma, and dehiscence.

For pain monitoring, patients submit a daily Numeric Rating Scale (NRS) 0–10 pain score with a descriptor of the pain character (incisional vs. deep, constant vs. intermittent), pain location, and current analgesic use. Pain score trends over time provide the clinical team with data to: adjust analgesic prescriptions (reduce narcotic use as scores decline — important for supporting opioid stewardship and minimizing patient dependence risk), identify pain patterns inconsistent with expected healing (sudden pain spike on post-op day 14 in a patient with a breast implant may indicate early capsular contracture or seroma), and document the adequacy of pain management in the medical record.

For activity restriction compliance, patients complete a daily checklist in the RTM app: no lifting above 10 lbs (for breast and abdominal procedures), no sleeping flat for face and rhinoplasty patients (head elevation compliance), use of compression garment for liposuction and abdominoplasty patients (duration and hours-per-day compliance), and avoidance of submersion bathing until wound closure is confirmed. Non-compliance flags are reviewed by the clinical team and addressed with patient education reinforcement — documented in the RTM record as a therapeutic intervention.

For abdominoplasty and body contouring patients, compression garment compliance directly impacts seroma rates. A patient who removes the garment early due to discomfort and develops a seroma requiring repeat aspiration could have been identified as an early non-compliance risk if RTM daily checklists flagged 3 consecutive days of "no garment worn." Early intervention — a coordinator call to troubleshoot garment fit or comfort — prevents the complication rather than managing it after the fact.

RTM CPT Code Revenue for Reconstructive Patients

The RTM revenue model for plastic surgery reconstructive patients follows the same CPT code structure as other RTM programs but with a shorter average enrollment duration — reconstruction patients are typically enrolled for 2–4 months (the active healing and monitoring period), whereas chronic disease RTM programs may run indefinitely.

CPT 98975 (initial setup, billed once per enrollment): $18.73 Medicare. For 20 new reconstructive patients enrolled per month, this generates approximately $374.60/month in setup fees.

CPT 98977 (monthly musculoskeletal/device supply fee): $53.98 Medicare. For 60 enrolled patients in any given month (reflecting a rolling 3-month enrollment window with 20 new patients per month), monthly 98977 revenue = $3,238.80.

CPT 98980 (first 20 minutes RTM management): $50.18 Medicare. For 60 enrolled patients with all meeting the 20-minute minimum: $3,010.80/month.

CPT 98981 (additional 20 minutes): $40.84 Medicare. For reconstructive patients in the first 4–6 weeks post-op, complex wound monitoring, drain output concerns, and pain management questions make additional management time more common than in chronic disease RTM. Assume 40% of enrolled patients generate at least one 98981 unit: 24 × $40.84 = $980.16/month.

Total monthly RTM revenue (Medicare rates): $374.60 (setup, variable) + $3,238.80 + $3,010.80 + $980.16 = $7,604.36 in a month where 20 new patients are enrolled. Months with lower enrollment will generate less setup revenue but maintain the recurring 98977 + 98980 base.

Commercial payer rates are typically 20–40% above Medicare for RTM codes. A practice with 50% commercial patients in the reconstructive cohort can reasonably project blended monthly RTM revenue of $8,000–$9,500 for a 60-patient enrolled cohort — generated by clinical oversight that would otherwise occur informally and without billing.

Patient Eligibility and Enrollment for Plastic Surgery RTM

Not every post-operative plastic surgery patient is an appropriate RTM candidate. Enrollment criteria should be defined and applied consistently to ensure both clinical appropriateness and billing compliance.

Appropriate RTM candidates in plastic surgery: patients with active surgical wounds requiring healing surveillance (incisions, donor sites, flap reconstructions), patients with drains in place, patients with implant-based reconstruction in the first 6 months post-placement, patients with documented wound complications (dehiscence, infection, seroma) under management, patients with complex multi-site procedures (combined procedures with multiple healing areas), and high-risk patients (diabetes, BMI > 35, prior radiation, immunosuppression) where complication risk justifies intensified monitoring.

Patients generally not appropriate for RTM (or where RTM adds little over routine follow-up): uncomplicated cosmetic patients with minor procedures (botox follow-up, minor scar revision), patients without smartphone access or caregiver smartphone support, patients who live within 10 minutes of the office and have no barrier to frequent in-person follow-up for minor concerns, and patients whose wounds have fully epithelialized and require no further active monitoring.

The enrollment conversation should happen at the pre-operative appointment or immediately after surgery. Frame RTM as a clinical benefit to the patient — you are providing more attentive post-operative oversight, with a clinical team reviewing their healing progress regularly between appointments. Most reconstructive patients are highly motivated to participate, as they understand the stakes of post-surgical complications. Consent to RTM should be documented as part of the pre-operative informed consent process and include a description of the data to be collected, the monitoring frequency, and who will be reviewing submissions.

Integration with Post-Operative Visit Scheduling

RTM does not replace post-operative visits — it supplements them with continuous surveillance data that makes each in-person visit more efficient and clinically informed. The integration of RTM data into the post-operative visit workflow is where the clinical and operational value of the program is most evident.

In a traditional post-operative visit without RTM data, the surgeon must spend time gathering the week's history: any concerning changes? Pain levels? Drain output? Wound appearance? This history-gathering takes 5–8 minutes of a 15-minute post-op visit. With RTM data, the surgeon reviews the week's photo submissions, pain scores, drain output log, and compliance checklist before entering the room — arriving with a pre-formed clinical assessment. The visit focuses on physical examination findings, the patient's questions, and the plan — reducing the visit time needed for information gathering and improving the quality of the clinical interaction.

For scheduling integration, the RTM platform should flag patients with concerning trends for priority review before the visit. If a patient's wound photo from 2 days ago showed an area of opening at the medial aspect of the incision, that finding should be flagged in the pre-visit chart review — not discovered for the first time when the surgeon examines the wound at the visit. This pre-visit clinical briefing is one of the most operationally valuable features of a well-integrated RTM system.

For patients who require an unscheduled visit based on RTM findings (concerning drain output spike, wound appearance change, pain score elevation), the RTM data justifies the urgent visit and provides an advance record of the problem. The unscheduled visit is billed as a standard E&M encounter (typically 99213–99214) without RTM impact on that day's billing — RTM management codes cover the remote monitoring activity, and the in-person visit is billed separately based on its own medical decision-making complexity.